Abstract
Advances in hematopoietic cell transplantation have reduced the toxicity of both allogeneic and autologous transplantation. Decisions regarding the feasibility of transplantation should be individualized, and based upon physiological rather than chronological age.
Publication types
-
Research Support, U.S. Gov't, P.H.S.
-
Review
MeSH terms
-
Acute Disease
-
Adult
-
Age Factors
-
Aged
-
Bone Marrow Transplantation* / adverse effects
-
Bone Marrow Transplantation* / methods
-
Chronic Disease
-
Graft vs Host Disease / etiology
-
Hematologic Neoplasms / therapy
-
Hematopoietic Stem Cell Transplantation / adverse effects
-
Hematopoietic Stem Cell Transplantation / methods
-
Humans
-
Lymphocyte Depletion
-
Middle Aged
-
Prognosis
-
Transplantation, Autologous
-
Transplantation, Homologous
-
Treatment Outcome